ATNF
180 Life Sciences Corp. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website 180lifesciences.com
- Employees(FY) 5
- ISIN US68236V3024
Performance
-22.55%
1W
+6.76%
1M
-59.49%
3M
-78.68%
6M
-61.05%
YTD
-91.5%
1Y
Profile
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Technical Analysis of ATNF 2024-05-10
Overview:
In analyzing the technical indicators for ATNF over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-15 23:53
- 2024-03-13 20:30
- 2024-02-25 18:00
- 2023-12-03 20:00
- 2023-11-27 20:00
180 Life Sciences Announces Review of Strategic Alternatives(Globenewswire)
- 2023-08-14 04:29
- 2023-08-09 20:46
- 2023-08-06 21:00
- 2023-08-02 20:00
- 2023-07-30 20:00
- 2023-04-10 04:30
- 2023-04-05 01:00
- 2023-02-26 19:30
- 2023-02-22 18:30
- 2023-02-22 03:30
- 2023-01-24 19:45
- 2023-01-16 19:00
- 2023-01-04 19:30
- 2023-01-03 19:30
- 2022-12-28 19:30
- 2022-12-22 19:00
- 2022-12-20 01:11
- 2022-12-15 20:00
- 2022-11-30 04:00
- 2022-11-20 19:30
- 2022-11-14 23:37
- 2022-11-14 19:00
- 2022-09-25 20:30
180 Life Sciences Issues Letter to Stockholders(Yahoo Finance)
- 2022-08-21 20:30
- 2022-07-26 20:30
Page 1 of 3
previousnext